Pharmaceutical patenting in the European Union: reform or riddance

被引:0
作者
Livio Garattini
Marco Badinella Martini
Pier Mannuccio Mannucci
机构
[1] Institute for Pharmacological Research Mario Negri IRCCS,
[2] IRCCS “Ca’ Granda Maggiore Policlinico” Hospital Foundation,undefined
来源
Internal and Emergency Medicine | 2022年 / 17卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:937 / 939
页数:2
相关论文
共 12 条
[1]  
Cockburn I(2015)The importance of patents to innovation: updated cross-industry comparisons with biopharmaceuticals Expert Opin Ther Pat 25 739-742
[2]  
Long G(2017)Between pharmaceutical patents and European patients: is a compromise still possible? Expert Opin Ther Pat 27 1073-1076
[3]  
Garattini L(2010)Patent protection strategies J Pharm Bioallied Sci 2 2-7
[4]  
Padula A(2015)Drug patents and intellectual property rights Eur J Clin Pharmacol 71 403-409
[5]  
Gupta H(2017)Healthcare innovation and patent law's 'pharmaceutical privilege': is there a pharmaceutical privilege? And if so, should we remove it? Health Econ Policy Law 12 453-470
[6]  
Kumar S(undefined)undefined undefined undefined undefined-undefined
[7]  
Roy S(undefined)undefined undefined undefined undefined-undefined
[8]  
Gaud R(undefined)undefined undefined undefined undefined-undefined
[9]  
Raj GM(undefined)undefined undefined undefined undefined-undefined
[10]  
Priyadarshini R(undefined)undefined undefined undefined undefined-undefined